Pro-Adrenomedullin Associates with Congestion in Acute Heart Failure Patients
Elevated pro-adrenomedullin is associated with in-hospital worsening heart failure and with death during follow-up in patients with acute heart failure. Further research is needed to validate this finding and to explore the ability of pro-adrenomedullin to guide decongestive treatment.
Authors
- Christina Magnussen (ORCID: https://orcid.org/0000-0002-5102-0955)
- Stefan Blankenberg (ORCID: https://orcid.org/0000-0001-6488-2362)
- Lisa Besch
- Caroline Kellner (ORCID: https://orcid.org/0009-0000-9693-4622)
- Benedikt Schrage (ORCID: https://orcid.org/0000-0001-9041-3922)
- Paulus Kirchhof (ORCID: https://orcid.org/0000-0002-1881-0197)
- Benedikt N. Beer (ORCID: https://orcid.org/0000-0003-4315-2533)
- Jonas Sundermeyer (ORCID: https://orcid.org/0000-0002-0076-2211)
- Angela Dettling (ORCID: https://orcid.org/0000-0003-0992-0236)
- Saman Keshtkaran
Institutions
- Universität Hamburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- German Centre for Cardiovascular Research (DE)
- University of Birmingham (GB)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2024-08-20
- DOI
- https://doi.org/10.1002/ehf2.15007
- Citations
- 4
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Deutsches Zentrum für Herz-Kreislaufforschung
- Abiomed
- British Heart Foundation
- European Commission
- Deutsche Forschungsgemeinschaft
- Fondation Leducq
- Else Kröner-Fresenius-Stiftung
- Universität Hamburg
- Deutsche Stiftung für Herzforschung
- Dr. Rolf M. Schwiete Stiftung
- Medical Research Council
- Universitätsklinikum Hamburg-Eppendorf